DK148677A - PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS - Google Patents

PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS

Info

Publication number
DK148677A
DK148677A DK148677A DK148677A DK148677A DK 148677 A DK148677 A DK 148677A DK 148677 A DK148677 A DK 148677A DK 148677 A DK148677 A DK 148677A DK 148677 A DK148677 A DK 148677A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
anesthetically effective
effective steroids
steroids
Prior art date
Application number
DK148677A
Other languages
Danish (da)
Inventor
G H Phillipps
G B Ewan
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK148677A publication Critical patent/DK148677A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK148677A 1976-04-05 1977-04-04 PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS DK148677A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13707/76A GB1581234A (en) 1976-04-05 1976-04-05 11a - amino - 3a - hydroxysteroids

Publications (1)

Publication Number Publication Date
DK148677A true DK148677A (en) 1977-10-06

Family

ID=10027931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK148677A DK148677A (en) 1976-04-05 1977-04-04 PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS

Country Status (19)

Country Link
JP (1) JPS52142056A (en)
AU (1) AU517206B2 (en)
BE (1) BE853227A (en)
DE (1) DE2715078A1 (en)
DK (1) DK148677A (en)
ES (1) ES457507A1 (en)
FI (1) FI771046A (en)
FR (2) FR2347382A1 (en)
GB (1) GB1581234A (en)
IE (1) IE45276B1 (en)
IL (1) IL51816A (en)
IT (1) IT1073232B (en)
LU (1) LU77064A1 (en)
NL (1) NL7703667A (en)
NO (1) NO771197L (en)
NZ (1) NZ183775A (en)
PL (1) PL197186A1 (en)
SE (1) SE7703929L (en)
ZA (1) ZA772029B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7288081A (en) * 1980-07-16 1982-01-21 Glaxo Group Limited 11alpha-amino-androstanes
SE8104393L (en) * 1980-07-16 1982-01-17 Glaxo Group Ltd LLALFA-AMINO androstanes
JPS57158800A (en) * 1981-03-02 1982-09-30 Glaxo Group Ltd 11 alpha-amino-3 beta-hydroxyandrostane compound
JPS57203099A (en) * 1981-05-29 1982-12-13 Glaxo Group Ltd 11 alpha-amino-androstane compound
AU8428782A (en) * 1981-05-29 1982-12-02 Glaxo Group Limited 11-alpha-amino-androstane
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
FR2910002B1 (en) * 2006-12-13 2009-01-30 Sanofi Aventis Sa NOVEL METHOD FOR THE DIASTEREOSELECTIVE OBTAINING OF A PRIMARY CHIRAL AMINE ON A STEROID
JP2010037243A (en) * 2008-08-04 2010-02-18 Mitsubishi Rayon Co Ltd Method for producing norbornene lactone monomer
ES2738526T3 (en) 2011-10-14 2020-01-23 Sage Therapeutics Inc Compounds 19-norpregnano 3,3-disubstituted, compositions and uses thereof
PL2806877T3 (en) 2012-01-23 2020-06-01 Sage Therapeutics, Inc. Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
SG11201508550XA (en) 2013-04-17 2015-11-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
CA2909546C (en) 2013-04-17 2019-01-22 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
SI3021852T1 (en) * 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3035940B1 (en) 2013-08-23 2018-10-17 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PL3206493T3 (en) 2014-10-16 2021-01-25 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SG10202009861SA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
LT3224269T (en) * 2014-11-27 2020-07-10 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
PL3250210T3 (en) 2015-01-26 2021-07-26 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
DK3258939T3 (en) 2015-02-20 2022-12-12 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF
MA43815A (en) 2016-03-08 2021-04-07 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS, AND THEIR USES
CN116162121A (en) 2016-07-11 2023-05-26 萨奇治疗股份有限公司 C17, C20 and C21 substituted neuroactive steroids and methods of use thereof
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
CA3086189A1 (en) * 2017-12-22 2019-06-27 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
MA54594A (en) 2018-12-05 2022-04-06 Sage Therapeutics Inc NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF
MX2021014515A (en) 2019-05-31 2022-03-22 Sage Therapeutics Inc Neuroactive steroids and compositions thereof.
TW202114696A (en) * 2019-06-27 2021-04-16 美商賽吉醫療公司 Compositions and methods for treating cns disorders
EP3990468A1 (en) * 2019-06-27 2022-05-04 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2982775A (en) * 1957-05-06 1961-05-02 Schering Corp 11-oximino-, amino- and acylaminosteroids

Also Published As

Publication number Publication date
SE7703929L (en) 1978-10-27
AU517206B2 (en) 1981-07-16
BE853227A (en) 1977-10-04
FR2347382B1 (en) 1982-01-08
IL51816A0 (en) 1977-06-30
DE2715078A1 (en) 1977-10-13
IE45276B1 (en) 1982-07-28
NL7703667A (en) 1977-10-07
AU2394277A (en) 1978-10-12
GB1581234A (en) 1980-12-10
IE45276L (en) 1977-10-05
FR2347382A1 (en) 1977-11-04
NO771197L (en) 1977-10-06
IT1073232B (en) 1985-04-13
PL197186A1 (en) 1979-06-18
NZ183775A (en) 1979-12-11
JPS52142056A (en) 1977-11-26
ZA772029B (en) 1978-11-29
FI771046A (en) 1977-10-06
FR2485020A1 (en) 1981-12-24
ES457507A1 (en) 1978-03-16
LU77064A1 (en) 1979-01-18
IL51816A (en) 1981-09-13

Similar Documents

Publication Publication Date Title
DK148677A (en) PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS
DK3577A (en) PROCEDURE FOR THE PREPARATION OF ANESTHETICALLY EFFECTIVE STEROIDS
DK30277A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED PHENYLAMIDINES
DK377A (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYL-GLYCIN
DK244577A (en) PROCEDURE FOR THE PREPARATION OF HYDANTO INTERVENTIVES
DK276177A (en) PROCEDURE FOR THE PREPARATION OF GAMMAPYRON COMPOUNDS
DK577977A (en) PROCEDURE FOR THE PREPARATION OF ALFA-L-ASPARTYL-L-PHENYLALANIN METHYLES
DK339677A (en) PROCEDURE FOR THE PREPARATION OF 2-BENZYLPYRROLIDINES
DK587077A (en) PROCEDURE FOR THE PREPARATION OF ESTERES
DK144377A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK233477A (en) PROCEDURE FOR THE PREPARATION OF ANTIOTIC AGENTS
DK88777A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED AZAPURINES
DK271377A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED ARYLACETAMIDOCEPHALOSPORINES
DK144277A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK216977A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOBENZOXAZINES
DK575077A (en) PROCEDURE FOR THE PREPARATION OF 0-ALKYLED OXIMES
DK195077A (en) PROCEDURE FOR THE PREPARATION OF BENZODIAZEPINES
DK73277A (en) PROCEDURE FOR THE PREPARATION OF SULFONYLBENZIMIDAZOLES
DK575277A (en) PROCEDURE FOR THE PREPARATION OF BASIC SUBSTITUTED 0-PROPYLOXIMER
DK438277A (en) PROCEDURE FOR THE PREPARATION OF 9-CHLORO PREDISANOLONS
DK538977A (en) PROCEDURE FOR THE PREPARATION OF 17ALFA-HYDROXY-21-ACETOXY-PROGESTERONE
DK196577A (en) PROCEDURE FOR THE PREPARATION OF CHOLECYSTOKININ-PANCREOZYMIN-OCTAPEPTIDAMIDE SULFATESTER
DK564977A (en) PROCEDURE FOR THE PREPARATION OF ANTIRHINOVIRUS AGENTS
DK123177A (en) PROCEDURE FOR THE PREPARATION OF 7-ALCOXY-3-CHLOROMETHYL-3-CEPHEM COMPOUNDS
DK338677A (en) PROCEDURE FOR THE PREPARATION OF 3-ALCOXYCYPROHEPTADINES

Legal Events

Date Code Title Description
PBP Patent lapsed